The U.S. Food and Drug Administration is alerting users about a voluntary recall of the Johnson’s Baby Powder. Johnson & Johnson has recalled its product after FDA testing found chrysotile fibers (a form of asbestos) in a sample from one lot of the baby powder.
Testing talc-containing products for the presence of asbestos
The FDA has warned that the users who have Johnson’s Baby Powder lot #22318RB should immediately stop its use. Additionally, the agency has also advised the consumers to contact Johnson & Johnson for a refund.
The FDA always stands by the quality of its tests and results. And up till now, it isn’t aware of any adverse event linked with the exposure to a lot of affected Johnson’s Baby Powder. Asbestos is one of the known carcinogens.
If the talc mining sites aren’t chosen carefully, and steps for adequate purification of talc ore aren’t taken, it may lead to contamination of the product with asbestos. The FDA is taking all the necessary steps and performing tests to check talc-containing cosmetic products for asbestos.
The agency found that not all the talc contained asbestos and the majority of the product samples tested were free of asbestos. Ned Sharpless is Acting Commissioner and M.D. of the FDA. He said that this recall is of concern for all those people who have used the affected lot of products.
Moreover, he has also assured everyone that the FDA is taking these concerns quite seriously. And has committed to its obligation of protecting public health. Still, the agency continues the testing of talc-containing cosmetic products for the presence of asbestos. And hence, protecting the Americans from possible health risks.
Reporting of any adverse events linked with the use of cosmetics
Since 2018, the FDA has been conducting a continuous survey of talc products for asbestos. And up till now, it has tested nearly 50 cosmetic products. As part of this testing, the agency analyzed two samples of Johnson’s Baby Powder. One sample from lot #22318RB, and another one from lot #00918RA.
The results of testing showed that the former sample was positive for asbestos, and the latter one was negative. Since the start of testing, the agency has alerted users of any product tested positive for asbestos and has advised them to stop the use of affected products.
In accordance with the Federal Food, Drug and Cosmetic Act (FD&C Act), cosmetic products and ingredients except color additives don’t need FDA approval before they go into the market. But still, the agency has an obligation to monitor the cosmetic markets. And can take any suitable action for the consumers’ protection in the post-market setting.
The FDA has again requested the industries to list and register their products to the FDA’s Voluntary Cosmetics Registration Program. Moreover, it has also encouraged health care professionals and consumers to report any adverse event linked with the use of a cosmetic.
They should report such cases to the FDA’s MedWatch Adverse Event Reporting program by submitting a form. While the form can be submitted via fax at 1-800-FDA-0178 or online at MedWatch Online Voluntary Reporting Form.